3.98
Prelude Therapeutics Inc Aktie (PRLD) Neueste Nachrichten
Prelude Therapeutics (PRLD) Projected to Post Earnings on Wednesday - Defense World
Prelude Therapeutics Spikes: Can The Pipeline Keep Up? - RTTNews
Prelude Therapeutics (NASDAQ:PRLD) and CytoDyn (OTCMKTS:CYDY) Financial Analysis - Defense World
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.51% - Investing.com
Prelude Therapeutics (PRLD) to Present Preclinical Findings at A - GuruFocus
Can Prelude Therapeutics Incorporated stock hit analyst price targetsDay Trade & Real-Time Price Movement Reports - newser.com
Is Prelude Therapeutics Incorporated stock ready for a breakoutQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting - Yahoo Finance
Pattern recognition hints at Prelude Therapeutics Incorporated upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
What to do if you’re stuck in Prelude Therapeutics IncorporatedJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
What institutional flow reveals about Prelude Therapeutics Incorporated2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
How Prelude Therapeutics Incorporated stock reacts to oil pricesJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com
Is Prelude Therapeutics Incorporated stock a defensive play in 2025Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Volume spikes in Prelude Therapeutics Incorporated stock – what they meanJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Will Prelude Therapeutics Incorporated stock deliver shareholder valueJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com
Can Prelude Therapeutics Incorporated stock maintain operating marginsJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsPortfolio Performance Report & High Return Trade Guides - newser.com
Is Prelude Therapeutics Incorporated stock supported by innovation pipelineBear Alert & AI Enhanced Trade Execution Alerts - newser.com
Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings - AD HOC NEWS
Prelude Therapeutics Incorporat (PRLD) stock forecast and price target - Yahoo! Finance UK
What sentiment indicators say about Prelude Therapeutics Incorporated stockWatch List & Verified Technical Trade Signals - newser.com
Using flow based indicators on Prelude Therapeutics IncorporatedDip Buying & Safe Entry Zone Tips - newser.com
How to build a custom watchlist for Prelude Therapeutics Incorporated2025 Investor Takeaways & Weekly Momentum Picks - newser.com
Can Prelude Therapeutics Incorporated stock sustain free cash flow growthWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
Prelude Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
What machine learning models say about Prelude Therapeutics IncorporatedTrend Reversal & Reliable Trade Execution Plans - newser.com
Exit strategy if you’re trapped in Prelude Therapeutics IncorporatedJuly 2025 Action & Risk Controlled Swing Trade Alerts - newser.com
How Prelude Therapeutics Incorporated stock performs in interest rate cyclesInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Real time alert setup for Prelude Therapeutics Incorporated performanceInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Prelude Therapeutics Incorporated (PRLD) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Prelude Therapeutics Incorporated (PRLD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Real time pattern detection on Prelude Therapeutics Incorporated stock2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
How moving averages guide Prelude Therapeutics Incorporated trading2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):